People: Lydall Inc (LDL.N)

LDL.N on New York Stock Exchange

29.40USD
2 Jul 2015
Change (% chg)

$-0.31 (-1.04%)
Prev Close
$29.71
Open
$29.72
Day's High
$29.75
Day's Low
$29.14
Volume
17,241
Avg. Vol
31,057
52-wk High
$33.57
52-wk Low
$24.24

Search Stocks

Burdett, Kathleen 

Ms. Kathleen Burdett is Independent Director of Lydall, Inc. Ms. Burdettwas has served as Chair of our Audit Review Committee since April 2004 and as a member of our Corporate Governance Committee since April 2008. Ms. Burdett served as Vice President and Chief Financial Officer of Dexter Corporation (“Dexter”), a developer and manufacturer of nonwoven products primarily used in the food packaging, medical, and hygiene markets, specialty polymers primarily used in the aerospace and electronics markets and precise, reproducible biological, and biochemical products used for applications in the life sciences industry, from 1994 until Dexter’s merger with Invitrogen Corporation (“Invitrogen”), in 2000. From 2000 until her retirement in 2002, Ms. Burdett served as a consultant to Invitrogen. Prior to that, Ms. Burdett served as the Controller and Principal Accounting Officer of Dexter and as a member of the Board of Directors of Life Technologies, Inc. (“Life Technologies”), a majority owned subsidiary of Dexter, and as Chair of the Audit Committee and as a member of the Executive Committee and the Compensation Committee of Life Technologies.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

W. Duffy

--

Dale Barnhart

3,098,370

David Williams

973,884

James Laughlan

419,943

Chad McDaniel

1,081,560

William Lachenmeyer

--
As Of  30 Dec 2014
Search Stocks